Mesenchymal stem cell transfusion for desensitization of positive lymphocyte cross-match before kidney transplantation: Outcome of 3 cases

Cell Proliferation

Volumn 46, Issue 2, 2013, Pages 121-126

  Saadi, G ^a   Fadel, F ^a   El Ansary, M ^a   El Hamid, S Abd ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BASILIXIMAB; CREATININE; CYCLOSPORIN; DITHIOTHREITOL; HLA A ANTIGEN; HLA B ANTIGEN; IMMUNOGLOBULIN; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; B LYMPHOCYTE; BIOPSY; BLOOD DONOR; BLOOD GROUP A; BODY MASS; CASE REPORT; CHILD; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DESENSITIZATION; DRUG MEGADOSE; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERSENSITIVITY; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LYMPHOCYTE; LYMPHOCYTE CROSS MATCH; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEPHRECTOMY; OBESITY; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; RENAL GRAFT DYSFUNCTION; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; SINGLE DRUG DOSE; SPLENECTOMY; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; ANTIBODY SPECIFICITY; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; ISOANTIBODIES; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PLASMAPHERESIS; RISK FACTORS; SPLENECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875339462     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12012     Document Type: Article

References (19)

1. Glotz D, Haymann JP, Sansonetti N, Francois A et al. (1993) Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients. Transplantation 56, 335-337.
2. Gloor JM, DeGoey SR, Pineda AA et al. (2003) Overcoming a positive crossmatch in living-donor kidney transplantation. Am. J. Transplant. 3, 1017-1023.
3. Montgomery RA, Zachary AA, Racusen LC et al. (2000) Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70, 887-895.
4. Warren DS, Zachary AA, Sonnenday CJ et al. (2004) Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am. J. Transplant. 4, 561-568.
5. Comoli P, Ginevri F, Maccario R et al. (2008) Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol. Dial.Transplant. 23, 1196-1202.
6. Martin S, Claas F. (1993) Antibodies and cross matching for transplantation. In: Dayer P, Middleton D, eds. Histocompatibility Testing, A Practical Approach, P81. New York: Oxford University press.
7. Snanoudj R, Beaudreuil S, Arzouk N et al. (2005) Immunological strategies targeting B cells in organ grafting. Transplantation 79, S33-S36.
8. Poulsom R, Prodromidi EI, Pusey CD, Cook T (2006) Cell therapy for renal regeneration - time for some joined-up thinking? Nephrol. Dial. Transplant. 21, 3349-3353.
9. De Broe ME (2005) Tubular regeneration and the role of bone marrow cells: 'stem cell therapy' - a panacea? Nephrol. Dial. Transplant. 20, 2318-2320.
10. Abdi R, Fiorina P, Adra CN et al. (2008) Immunomodulation by mesenchymal stem cells. A potential therapeutic strategy for type I diabetes. Diabetes 57, 1759-1767.
11. Di Nicola M, Carlo-Stella C, Magni M et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843.
12. Corcione A, Benvenuto F, Ferretti E et al. (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367-372.
13. Ryan JM, Barry FP, Murphy JM, Mahon BP (2005) Mesenchymal stem cells avoid allogenic rejection. J. Inflamm. 2, 8-19.
14. Kuçi Z, Kuçi S, Zircher S et al. (2011) Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties. Cytotherapy 13, 1193-1204.
15. Perico N, Casiraghi F, Introna M et al. (2011) Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin. J. Am. Soc. Nephrol. 6, 412-422.
16. Zhang X, Jiao C, Zhao S (2009) Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev. 5, 402-409.
17. Le Blanc K, Rasmusson I, Sundberg B et al. (2004) Treatment of severe acute graft-versus- host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441.
18. Augello A, Tasso R, Negrini SM et al. (2005) Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35, 1482-1490.
19. Sordi V, Piemonti L (2011) Therapeutic plasticity of stem cells and allograft tolerance. Cytotherapy 13, 647-660.